▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3138 by analyst upside · 2026-06-27
URGN
UroGen Pharma Ltd.
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
+6.8%
implied upside to consensus target
Current Price $34.54
Consensus Target $36.88
Bull Target $45.0
Bear Target $18.0
Analysts Covering 8
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
6
Hold
1
Sell
0
52-Week Low $12.73
52-Week High $36.08
YTD Return +52.1%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E 28.1x
EPS (TTM) $-2.74
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $140M
Profit Margin -94.8%
52-WEEK RANGE
52-Week Low $12.73
52-Week High $36.08
Current Price $34.54
Bear Target $18.0
Bull Target $45.0
● Now $34.54 ● Target $36.88
TRADING DATA
Avg Volume 790K
YTD Return +52.1%
Analyst Count 8
Consensus Buy
Upside to Target +6.8%
Last Updated 2026-06-27

ANALYST SUMMARY

UroGen Pharma Ltd. (URGN) is currently trading at $34.54 with a Wall Street consensus price target of $36.88, implying potential upside of 6.8% over the next 12 months. 8 analysts currently cover URGN, with a consensus rating of Buy - 88% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $45.0, while the most cautious has a target of $18.0.

URGN operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 52.1% year-to-date and is currently trading near the upper end of its 52-week range of $12.73 – $36.08.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

AVAH +16.1%
Aveanna Healthcare Holdings Inc.
$2B · P/E 7.2x · Buy
HCSG +7.8%
Healthcare Services Group, Inc.
$2B · P/E 24.8x · Hold
SEM +0.8%
Select Medical Holdings Corporation
$2B · P/E 15.4x · Hold
MD -6.1%
Pediatrix Medical Group, Inc.
$2B · P/E 12.0x · Hold
INSP +11.4%
Inspire Medical Systems, Inc.
$1B · P/E 9.9x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for URGN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. reit
Buy → Buy 2026-06-03 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-05-18 31% win rate (48 calls)
HC Wainwright & Co. — Reiterated
Buy → Buy 2026-05-11 31% win rate (48 calls)
Oppenheimer — Reiterated
Outperform → Outperform 2026-05-07 14% win rate (7 calls)
D. Boral Capital — Reiterated
Buy → Buy 2026-03-31 32% win rate (25 calls)
D. Boral Capital — Reiterated
Buy → Buy 2026-03-02 32% win rate (25 calls)
D. Boral Capital — Reiterated
Buy → Buy 2026-01-23 32% win rate (25 calls)
D. Boral Capital — Reiterated
Buy → Buy 2026-01-05 32% win rate (25 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
53
out of 100
Coverage depth
17/30
Consensus clarity
14/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →